NCT01055899View on ClinicalTrials.gov

Safety Study of a Single Dose of REGN88(SAR153191)in Patients With Rheumatoid Arthritis

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions
Rheumatoid Arthritis
Interventions
BIOLOGICAL

REGN88

Single SC Dose

BIOLOGICAL

REGN88

Single SC Dose

BIOLOGICAL

REGN88

Single SC Dose

Trial Locations (2)

Unknown

Duncansville

Dallas

Sponsors

Collaborators (1)

Sanofi
All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

Regeneron Pharmaceuticals

INDUSTRY